CPC Main Group Additional Only
A61M 2230/00 Measuring parameters of the user
Filing statistics
CPC A61M 2230/00 belongs to the parent subclass A61M, which recorded 405,895 patent applications worldwide between 2013 and 2023. Annual filings grew from 28,233 in 2013 to 30,654 in 2023 (+9%), peaking at 43,390 applications in 2020. The most active applicants in class A61 are PHILIPS ELECTRONICS (20,621 applications), NOVARTIS (15,792 applications) and ROCHE (14,303 applications).
Source: EPO PATSTAT, worldwide filings
12 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61M 2230/005 Parameter used as control input for the apparatus
- A61M 2230/04 Heartbeat characteristics, e.g. ECG, blood pressure modulation
- A61M 2230/08 Other bio-electrical signals
- A61M 2230/18 Rapid eye-movements [REM]
- A61M 2230/20 Blood composition characteristics
- A61M 2230/30 Blood pressure (A61M2230/04 takes precedence)
- A61M 2230/40 Respiratory characteristics
- A61M 2230/50 Temperature
- A61M 2230/60 Muscle strain, i.e. measured on the user
- A61M 2230/62 Posture
- A61M 2230/63 Motion, e.g. physical activity
- A61M 2230/65 Impedance, e.g. conductivity, capacity
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513